TY - JOUR
T1 - Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT ph-triggered delivery
AU - Llinàs, Maria C.
AU - Martínez-Edo, Gabriel
AU - Cascante, Anna
AU - Porcar, Irene
AU - Borrós, Salvador
AU - Sánchez-García, David
N1 - Funding Information:
M.C.L and G.M.E are grateful to IQS for financial support. We would like to thank Generalitat de Catalunya for the consolidated Research Group Grant (SGR) 1170 to GEMAT. The authors acknowledge the technical assistance of Dr. Alejandro Sánchez-Chardi and Ms. Nuria Barba Bosch from the Microscopy Facility of the Universitat Autó noma de Barcelona (UAB).
Publisher Copyright:
© 2018 The Author(s).
PY - 2018
Y1 - 2018
N2 - A dual doxorubicin/camptothecin (DOX/CPT) pH-triggered drug delivery mesoporous silica nanoparticle (MSN)-based nano-vehicle has been prepared. In this drug-delivery system (DDS), CPT is loaded inside the pores of the MSNs, while DOX is covalently attached to the surface of an aldehyde-functionalized MSN through a dihydrazide–polyethylene glycol chain. Thus, DOX and the linker act as pH-sensitive gatekeeper. The system is versatile and easy to assemble, not requiring the chemical modification of the drugs. While at physiological conditions the release of the drugs is negligible, at acidic pH a burst release of DOX and a gradual release of CPT take place. In vitro cytotoxicity tests have demonstrated that this DDS can deliver efficiently DOX and CPT for combination therapy.
AB - A dual doxorubicin/camptothecin (DOX/CPT) pH-triggered drug delivery mesoporous silica nanoparticle (MSN)-based nano-vehicle has been prepared. In this drug-delivery system (DDS), CPT is loaded inside the pores of the MSNs, while DOX is covalently attached to the surface of an aldehyde-functionalized MSN through a dihydrazide–polyethylene glycol chain. Thus, DOX and the linker act as pH-sensitive gatekeeper. The system is versatile and easy to assemble, not requiring the chemical modification of the drugs. While at physiological conditions the release of the drugs is negligible, at acidic pH a burst release of DOX and a gradual release of CPT take place. In vitro cytotoxicity tests have demonstrated that this DDS can deliver efficiently DOX and CPT for combination therapy.
KW - Camptothecin
KW - Combination therapy
KW - Doxorubicin
KW - Dual release
KW - Mesoporous silica nanoparticles
UR - http://www.scopus.com/inward/record.url?scp=85054352244&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_univeritat_ramon_llull&SrcAuth=WosAPI&KeyUT=WOS:000432632100003&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.1080/10717544.2018.1472678
DO - 10.1080/10717544.2018.1472678
M3 - Article
C2 - 29779394
AN - SCOPUS:85054352244
SN - 1071-7544
VL - 25
SP - 1137
EP - 1146
JO - Drug Delivery
JF - Drug Delivery
IS - 1
ER -